My take on the undervalued SP:
There are very few ASX companies which have patents as their key assets.
Of those, the ones which are valued highly already already have a revenue stream eg. CSL, COH.
The current market internationally is very nervous and that's why people are index hugging. Only about 20% of allocation of institutional investors is for speculative stock and there is little understanding of the difference between a stock which is more certain of achieving its potential (like AHZ or ADO) and those who are struggling with the science and with funding.
The market in Australia just wants to see dividends and income and has little or no patience or understanding of biotechs.
This means a colossal opportunity for those investors who are agile enough to take advantage, and patient enough to see it through.
Don't sweat the small stuff IMO, and that includes the current SP. It's going to be history one day, and IMO you'll be happy you held LT.
Add to My Watchlist
What is My Watchlist?
